| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/14/2002 | WO2002011665A2 Association of a purine and a nonsteroidal anti-inflammatory drug for treating sexual dysfunction |
| 02/14/2002 | WO2002011540A1 Rotavirus vaccine formulations |
| 02/14/2002 | WO2001072264A3 Pro-liposomal encapsulated preparations (iv) |
| 02/14/2002 | WO2001066115A3 Acetylsalicylic acid solutions |
| 02/14/2002 | WO2001062283A3 Mucosal adjuvant formulation |
| 02/14/2002 | WO2001058474A3 Microencapsulation and sustained release of biologically active agent |
| 02/14/2002 | WO2001055092A3 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents |
| 02/14/2002 | WO2001054675A3 Pharmaceutical compositions comprising terbinafine |
| 02/14/2002 | WO2001049685A3 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 02/14/2002 | WO2001049274A3 Methods for pulmonary delivery of interleukin-2 |
| 02/14/2002 | WO2001049252A3 Oil-in-water type cosmetic or dermatological preparations |
| 02/14/2002 | WO2001041807A3 Transmucosal composition containing a phosphodiesterase inhibitors for the treatment of erectile dysfunction |
| 02/14/2002 | WO2001041742A3 Antiviral medication |
| 02/14/2002 | WO2001039749A3 Fast dissolving composition with prolonged sweet taste |
| 02/14/2002 | WO2001019400A3 Pharmaceutical composition in the form of a nucleic acid lipid complex, the production thereof and its use in gene therapy |
| 02/14/2002 | WO2000059469A9 Endodontic fibers and methods of use therefor |
| 02/14/2002 | WO2000051565A9 Encapsulation of bioactive complexes in liposomes |
| 02/14/2002 | US20020019606 Microprocessor controlled ambulatory medical apparatus with hand held communication device |
| 02/14/2002 | US20020019447 Physical forms of clarified hydrocolloids of undiminished properties and method of producing same |
| 02/14/2002 | US20020019446 Polymeric drug formulations |
| 02/14/2002 | US20020019445 Topical applying |
| 02/14/2002 | US20020019442 Amphiphilic fluorine derivatives with telomeric structures; preparation procedure and biomedical applications |
| 02/14/2002 | US20020019431 Porous celecoxib matrices and methods of manufacture thereof |
| 02/14/2002 | US20020019421 Compositions and therapy for substance addiction |
| 02/14/2002 | US20020019418 Methods of preventing breast cancer |
| 02/14/2002 | US20020019398 Methods of making and using N-desmethylzopiclone |
| 02/14/2002 | US20020019377 Combination therapy for inhibiting sphincter incontinence |
| 02/14/2002 | US20020019372 New medical use; ophthalmic composition, treating nephrotoxicity, ischemia- and drug-induced acute renal failure, and glomerulonephritis, and skin abrasions, cuts, and burns |
| 02/14/2002 | US20020019369 Injectable drug delivery systems with cyclodextrin-polymer based hydrogels |
| 02/14/2002 | US20020019367 Compositions and methods for modulation of vascular structure and/or function |
| 02/14/2002 | US20020019365 Encapsulation is dissolution resistant at a pH of about 4 to 5 or less and dissolves at a pH of greater than about 4 to 5 |
| 02/14/2002 | US20020019358 Compositions and methods for in vivo delivery of polynucleotide-based therapeutics |
| 02/14/2002 | US20020019357 Use of magnesium (mg2+) for the preparation of a therapeutic composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy |
| 02/14/2002 | US20020019354 Method of treatment of seborrheic dermatitis |
| 02/14/2002 | US20020019350 Targeted angiogenesis |
| 02/14/2002 | US20020019336 Sustained release drug compositions |
| 02/14/2002 | US20020019334 Nutritional intervention composition for enhancing and extending satiety |
| 02/14/2002 | US20020018816 Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof |
| 02/14/2002 | US20020018815 Critical temperature, pressure of carbon dioxide |
| 02/14/2002 | US20020018814 Chlorhexidine formulations, new chlorhexidine salts, solutions containing these and their use |
| 02/14/2002 | US20020018812 Sponge-like or foam |
| 02/14/2002 | US20020018810 Controlled release oxycodone compositions |
| 02/14/2002 | US20020018808 Vaccines against sterols |
| 02/14/2002 | US20020018805 Reuseable adhesive |
| 02/14/2002 | US20020018804 Biological bioadhesive composition and methods of preparation and use |
| 02/14/2002 | US20020018803 Administering racemic mixtures |
| 02/14/2002 | US20020018800 Two-stage transmucosal medicine delivery system for symptom relief |
| 02/14/2002 | US20020018795 Targeted therapeutic agent release devices and methods of making and using the same |
| 02/14/2002 | US20020018789 Cosmetics; containing fine pigments |
| 02/14/2002 | US20020018788 Trimethylglycine compound |
| 02/14/2002 | US20020018772 Super absorption coenzyme Q10 |
| 02/14/2002 | US20020018753 Mixture of drug, propellant and solvent |
| 02/14/2002 | US20020018732 Buffer solution for contact lenses |
| 02/14/2002 | US20020017305 Method of restoring endothelium of cornea |
| 02/14/2002 | US20020017299 Apparatus and method for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures |
| 02/14/2002 | US20020017296 Apparatus and method for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures |
| 02/14/2002 | US20020017295 Phospholipid-based powders for inhalation |
| 02/14/2002 | DE10038571A1 Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen Compositions and dosage forms for use in the oral cavity in Bhandlung mycoses |
| 02/14/2002 | DE10037707A1 Encapsulating liquid droplets, useful for pharmaceuticals, dyes or plant-protection agents, comprises first forming a polyelectrolyte film at the phase boundary of an emulsion |
| 02/14/2002 | DE10036871A1 Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe Dispersions for the formulation of poorly soluble drugs or little |
| 02/14/2002 | DE10035991A1 Nagellackzusammensetzung Nail polish composition |
| 02/14/2002 | DE10035891A1 Medizinischer Haftkleber mit einer zweiphasigen Klebermatrix aus Polyacrylaten und Polyaminsalzen Medical adhesive with a two-phase adhesive matrix of polyacrylates and polyamine salts |
| 02/14/2002 | DE10031043A1 Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung Delayed-release preparations of quinolone antibiotics and methods for their preparation |
| 02/14/2002 | CA2634715A1 6.alpha.,9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl)oxy}-11.beta.-hydroxy-16.alpha-methyl-3-oxo-androsta-1,4-diene-17.beta.carbothioic acids-fluoromethyl ester as an anti-inflammatory agent |
| 02/14/2002 | CA2420066A1 Use, in combination, of a purine activity and a nonsteroidal anti-inflammatory drug for preparing an anti-thrombotic and/or anti-inflammatory drug |
| 02/14/2002 | CA2419060A1 Indole compounds useful for the treatment of cancer |
| 02/14/2002 | CA2419042A1 Medicine for fighting against sexual dysfunction |
| 02/14/2002 | CA2418960A1 Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation |
| 02/14/2002 | CA2418915A1 Stable pergolide mesylate and process for making same |
| 02/14/2002 | CA2418907A1 Hydrogel-driven drug dosage form |
| 02/14/2002 | CA2418904A1 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation |
| 02/14/2002 | CA2418383A1 Radiolabelled metal transport proteins as imaging agents |
| 02/14/2002 | CA2417973A1 Formulations of mometasone and a bronchodilator for pulmonary administration |
| 02/14/2002 | CA2417930A1 Pharmaceutical compositions containing lithium carbonate |
| 02/14/2002 | CA2417826A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/14/2002 | CA2417755A1 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 02/14/2002 | CA2417225A1 Electro-powder |
| 02/14/2002 | CA2416767A1 Liquid formulation of metformin |
| 02/14/2002 | CA2415333A1 Adenovirus e1b-55k single amino acid mutants and methods of use |
| 02/14/2002 | CA2386725A1 Novel pharmaceutical compositions of anti-tubercular drugs and process for their preparation |
| 02/13/2002 | EP1179558A1 Method of modifying surface layer of molded resin and apparatus for modifying surface layer of molded resin |
| 02/13/2002 | EP1179352A1 Topical composition for covering a skin lesion |
| 02/13/2002 | EP1179350A2 Encapsulated cell system for implantation into the human CNS |
| 02/13/2002 | EP1179349A1 W/O emulsion adjuvant compositions for vaccines |
| 02/13/2002 | EP1179344A1 Release-regulating preparations |
| 02/13/2002 | EP1179342A1 Immediate release medicinal compositions for oral use |
| 02/13/2002 | EP1179340A2 Compositions for the introduction of polyanionic materials into cells |
| 02/13/2002 | EP1179337A2 Use of polymers as film-forming barrier materials |
| 02/13/2002 | EP1179078A1 Starch granules containing a recombinant polypeptide of interest, method for obtaining same and uses |
| 02/13/2002 | EP1178848A1 Bioadhesive hydrogels with functionalized degradable crosslinks |
| 02/13/2002 | EP1178833A1 Topical compositions for prostaglandin e 1? delivery |
| 02/13/2002 | EP1178832A1 Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics |
| 02/13/2002 | EP1178825A2 Adjuvant combination formulations |
| 02/13/2002 | EP1178819A2 Glutathione reductase for therapy and prophylaxis of aids |
| 02/13/2002 | EP1178818A1 A stable composition comprising epidermal growth factor as an active ingredient |
| 02/13/2002 | EP1178812A2 Conditioned cell culture medium compositions and methods of use |
| 02/13/2002 | EP1178811A1 Electrolyte gels for maintaining hydration and rehydration |
| 02/13/2002 | EP1178809A1 Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate |
| 02/13/2002 | EP1178808A1 Pharmaceutical composition |
| 02/13/2002 | EP1178806A1 Transdermal device for the application of testosterone or one of the derivatives thereof |